Products

Our Catalogue (PDF) »

424 kb

Peptides

Tyr2 (C0101)

  • Sequence: c[YRGDLAYp(NMe)K]
  • Synonyms: „Tyr2“
  • Composition: TFA salt
  • Appearance: microcrystalline, colourless powder
  • Purity: > 95 % (UPLC, 210-220 nm)
  • Filling size: 1, 10, 100, 500, 1000 mg (net peptide)
  • Purpose: Not for human use

Tyr2-alkyne (C0201)

  • Sequence: c[YRGDLAYp(NMe)K(4-pentynoic amide)]
  • Synonyms: „Tyr2-alkyne“
  • Composition: TFA salt
  • Appearance: microcrystalline, colourless powder
  • Purity: > 95 % (UPLC, 210-220 nm)
  • Filling size: 1, 10, 100, 500, 1000 mg (net peptide)
  • Purpose: Not for human use

Tyr2-protected (C0301)

  • Sequence: c[Y(tBu)R(Pbf)GD(tBu)LAY(tBu)p(NMe)K]
  • Synonyms: „protected Tyr2“
  • Composition: TFA salt
  • Appearance: microcrystalline, colourless powder
  • Purity: > 95 % (UPLC, 210-220 nm)
  • Filling size: 1, 10, 100, 500, 1000 mg (net peptide)
  • Purpose: Not for human use

Tyr2-azide (C0209)

  • Sequence: c[Y(tBu)R(Pbf)GD(tBu)LAY(tBu)p(NMe)K]COCH2N3
  • Composition: TFA salt
  • Appearance: microcrystalline, colourless powder
  • Purity: > 95 % (UPLC, 210-220 nm)
  • Filling size: 1, 10, 100, 500, 1000 mg (net peptide)
  • Purpose: Not for human use

Bifunctional Chelators

TRAP (B0101)

  • Compound: 1,4,7-triazacyclononane-1,4,7-tris[methylene(2-carboxyethyl)phosphinic acid]
  • Composition: hydrate (1-2 H2O)
  • Appearance: microcrystalline, colourless powder
  • Purity: > 98 % (NMR)
  • Filling size: 1 g
  • Literature: 10.1002/chem.200903281,
    10.1002/chem.201103503

TRAP-Triazide (B0201)

  • Compound: TRAP(HN-CH2CH2CH2-N3)3
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Literature: 10.1039/c5dt00576k,
    10.1039/d3md00365e

TRAP-Diazide (B0202)

  • Compound: TRAP(HN-CH2CH2CH2-N3)2
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Literature: 10.2967/jnumed.116.182824

TRAP-Monoazide (B0203)

  • Compound: TRAP(HN-CH2CH2CH2-N3)
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Literature: 10.2967/jnumed.116.182824

DOTPI (B0102)

  • Compound: 1,4,7,10-tetraazacyclododecane-1,4,7-10-tetrakis[methylene(2-carboxyethyl)phosphinic acid]
  • Composition: hydrate (1-3 H2O)
  • Appearance: microcrystalline, colourless powder
  • Purity: > 98 % (NMR)
  • Filling size: 1 g
  • Literature: 10.1002/chem.201300338,
    10.3389/fchem.2018.00107

DOTPI-Tetraazide (B0501)

  • Compound: DOTPI(HN-CH2CH2CH2-N3)4
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Literature: 10.3389/fchem.2018.00107,
    10.1039/D4MD00073K

DOTPI-Triazide (B0502)

  • Compound: DOTPI(HN-CH2CH2CH2-N3)3
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Literature: 10.1021/acs.bioconjchem.4c00481

DOTPI-cis-Diazide (B0503)

  • Compound: DOTPI-cis-(HN-CH2CH2CH2-N3)2
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Literature: 10.1021/acs.bioconjchem.4c00481

DOTPI-trans-Diazide (B0504)

  • Compound: DOTPI-trans-(HN-CH2CH2CH2-N3)2
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 10 mg
  • Literature: 10.1021/acs.bioconjchem.4c00481

DOTPI-Monoazide (B0505)

  • Compound: DOTPI(HN-CH2CH2CH2-N3)
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Literature: 10.1021/acsomega.8b00035

DOTPI-PEG7-Triazide (B0508)

  • Compound: DOTPI(HN-(PEG7)-CH2-CH2-N3)
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • Purity: > 95 % (HPLC, 210-220 nm)
  • Filling size: 10 mg
  • Literature: 10.1021/acs.molpharmaceut.6c00256